Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05204069Completed
Randomised, open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Sensitivity of 3-dimensional visual screening protocol at 1 day. Started Jan 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05204069.